Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma
This study is designed to test (1) feasibility and efficiancy of new BACOPP regimen and (2) toxicity, overall response and FFTF.
HodgkinÂ´s Lymphoma
DRUG: Cyclophosphamide|DRUG: Adramycin|DRUG: Procarbacine|DRUG: Prednisone|DRUG: Vincristine|DRUG: Bleomycin|DRUG: Erythropoietin beta
This study is designed to test (1) feasibility and efficiancy of new BACOPP regimen and (2) toxicity, overall response and FFTF.